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Abstract The demand for pork and poultry products is strongly influenced by the consumers con-
cern for healthy and safe food. The topic of food safety mainly concentrates on Salmonella con-
tamination and is recently joined by the topic of antimicrobial resistance due to the use of antimi-
crobial growth promoters (AGP) in animal feed. Recent research findings on Flavomycin
(flavophospholipol), registered as an AGP for pigs, poultry and cattle, describe a reducing effect on
the development of antibiotic resistance and on the frequency of plasmid transfer.
Flavophospholipol does not induce an antibiotic resistance to antibiotics used for veterinary or
human therapy as it is not related to any antibiotic used for these purposes. Furthermore, it is
capable of reducing antibiotic resistance to other antibiotics. This effect seems to be yielded by
interfering in the biosynthesis of the plasmid bridge (pylus) which is a prerequisite for the genetic
transfer from one bacteria to another.
Introduction The demand for pork and poultry products is strongly influenced by the consumers
concern for healthy and safe food. The topic of food safety mainly concentrates on Salmonella
contamination and is recently joined by the topic of antimicrobial resistance due to the use of
antimicrobial growth promoters (AGP) in animal feed. Latest findings on flavophospholipol, regis-
tered as AGP for pigs, poultry and several other species, describe a reducing effect on the devel-
opment of antibiotic resistance and on the frequency of plasmid transfer.
Methods For the first investigation, conducted at the University of Maastricht (The Netherlands)
by van den Boogard (2002), 168 piglets were infected per oral administration with non-pathogen-
ic E. coli strains, with a known multi resistance pattern. Four weeks later the animal’s feces were
analyzed for the
occurrence of E.
coli and van-
comycin resistant
enterococci (VRE).
Furthermore the
isolated E. coli
strains were tested
for their sensitivity
to various antibi-
otics (ampicillin,
oxytetracycline,
trimethoprime, sul-
phamethoxazole,
ampicillin + oxytet-
racycline). After
that the piglets
were divided into
three groups. Feed
of group I served
as control, feed of
group II was sup-
plemented with
9ppm FlavomycinTM
and the feed for
group III was sup-
plemented with 15ppm avoparcin. Just before being
slaughtered animals feces was analyzed again in the
Human 
therapy
Veterinary
therapy
AGP
Lincosamides x x lincomycin
Nitrofurans x x Furox, nitrofurazone
Novobiocines x
Penicillines x x Peni- ampi-, amoxycillines
Cephalosporines x x Naxcel
Pleuromutilines x Tiamulin
Quinolones x x Baytril, saraflox
Rifamycines x x
Sulfonamides x x All sulfas, rofenaid
Tetracyclines x x Oxy- and chlortetracyclines
Macrolides x x + Tylosin, spiramycin1
Polypeptides x x + Bacitracin1
Orthosomycines ? x Avilamycin
Streptogamines x + Virginiamycin1
Glycopeptides x + Vancomycin, avoparcin1
Phosphoglycolipids x Flavophospholipol
Polyether ionophores x Salinomycin, monensin
Quinoxalines + Carbadox2, olaquindox2
Table 1: Major antibiotic classes and their usage in EU
+ = phased out
1 = phased out in 1999 due to resistance concerns
2 = phased out in 1999 due to other health concerns
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same manner as described above. The other trial was conducted by Riedl et. al (2000). Three van-
comycin A-resistant field strains of Enterococcus faecium were co-cultivated with some
Enterococcus faecium strains which were still sensible to vancomycin A. The transfer frequency
of vancomycin A resistance encoding plasmids was examined after giving various concentrations
of flavophospholipol to the nutrient solutions. For control vancomycin A itself was mixed into the
cultivated solution in different concentrations.
Results The first study clearly shows an increase of antibiotic resistance of the isolated E. coli
strains to all tested antibiotics in the control and in the avoparcin group. In the FlavomycinTM group
the occurrence of antibiotic resistances was unchanged or slightly diminished. The prevalence of
VRE in the vancomycin-group increased significantly during the trial as compared to the control
and flavophospholipol group. The other experiment resulted in a decrease of the transfer of van-
comycin A resistance encoding plasmids in a dose dependent manner in the presence of
flavophospholipol. In the presence of vancomycin this effect was not observed.
Conclusions
1. Flavophospholipol does not induce an antibiotic resistance to antibiotics used for veterinary 
or human therapy as it is not related to any antibiotic used for these purposes. 
2. Furthermore it is capable of reducing antibiotic resistance to other antibiotics. This effect 
seems to be yielded by interfering in the biosynthesis of the plasmid bridge (pylus) which is 
a prerequisite for the genetic transfer from one bacteria to another.
3. These findings confirm previous studies by Dealy and Moeller, which described 
flavophospholipol’s ability to significantly reduce the number of antibiotic-resistant 
Salmonella in pigs and calves.
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Figure 1: Comparison reduction in resistance 12 weeks
after oral colonisation with multi resistant E. coli (white=all
groups, light gray=controls, dark gray=avoparcin, and
black=Flavomycin). Average resistance level (%)= (number
cfu antibioticum containing plate/number cfu antibiuticum
free plate)x100; a:P<0.05 in comparison to the start of the
study; b: P<0.05 in comparison to the Flavomycin group.
Figure 2: Effect of different concentrations of
flavomycin on the transfer frequency of the
VanA plasmids in donor strains Aw2 (square)
2E121198 (triangle) and 2121198 (circle).
